<rdf:RDF xmlns="http://purl.org/rss/1.0/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:admin="http://webns.net/mvcb/"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
>
<channel rdf:about="http://www.informaworld.com/ampp/rss~content=t713643806">
<title>Leukemia and Lymphoma: Articles recently published in</title>
<link>http://www.informaworld.com/smpp/title~content=t713643806~db=all</link>
<description>informaworld: articles recently published in Leukemia and Lymphoma</description>
<image rdf:resource="http://www.informaworld.com/smpp/image?id=741287562" />
<dc:publisher>Informa Healthcare</dc:publisher>
<dc:title>Articles recently published in Leukemia and Lymphoma</dc:title>
<dc:description>RSS feed of the most recently published articles of Leukemia and Lymphoma</dc:description>
<dc:date>2009-11-01</dc:date>
<dc:format>undefined</dc:format>
<prism:publicationName>Leukemia and Lymphoma</prism:publicationName>
<prism:distributor></prism:distributor>
<prism:isPartOf rdf:resource="urn:issn:1042-8194"/>
<prism:issn>1042-8194</prism:issn>

<admin:generatorAgent rdf:resource="http://www.informaworld.com" />
<admin:errorReportsTo rdf:resource="mailto:help@www.informaworld.com" />
<sy:updatePeriod>weekly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2009-11-01T00:00+00:00</sy:updateBase>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414617~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414539~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414305~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414807~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414053~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414327~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414867~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413916~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414721~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414777~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414340~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413752~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414435~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414118~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413956~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414939~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413830~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414659~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414904~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414583~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414406~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414836~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414741~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414495~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414069~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413792~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414228~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414559~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413727~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414283~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413868~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413930~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413710~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413890~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414264~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916414634~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916413909~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916245123~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916244454~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916245147~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916245062~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916244379~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916244071~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916244248~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916245194~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916244573~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916245163~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916245182~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916244552~db=all~jumptype=rss" />
<rdf:li rdf:resource="http://www.informaworld.com/smpp/content~content=a916244352~db=all~jumptype=rss" />
</rdf:Seq>
</items>
</channel>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414617~db=all~jumptype=rss">
<title>Is there a role for bone scan in Hodgkin lymphoma in the age of 18 F-fluorodeoxyglucose positron emission tomography?</title>
<dc:title>Is there a role for bone scan in Hodgkin lymphoma in the age of 18 F-fluorodeoxyglucose positron emission tomography?</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414617~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903340596" />
<dc:creator>Martin, Peter</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1731</prism:startingPage>
<prism:endingPage>1732</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414539~db=all~jumptype=rss">
<title>Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?</title>
<dc:title>Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414539~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903308098" />
<dc:creator>Eichenauer, Dennis A.</dc:creator>
<dc:creator>Engert, Andreas</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1733</prism:startingPage>
<prism:endingPage>1734</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414305~db=all~jumptype=rss">
<title>Screening for microRNAs in myelodysplastic syndromes</title>
<dc:title>Screening for microRNAs in myelodysplastic syndromes</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414305~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903267567" />
<dc:creator>Eklund, Elizabeth A.</dc:creator>
<dc:creator>Platanias, Leonidas C.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1735</prism:startingPage>
<prism:endingPage>1736</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414807~db=all~jumptype=rss">
<title>The role of myeloid colony-stimulating factors in the treatment of acute lymphoblastic leukemia - more questions than answers?</title>
<dc:title>The role of myeloid colony-stimulating factors in the treatment of acute lymphoblastic leukemia - more questions than answers?</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414807~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903234013" />
<dc:creator>Ram, Ron</dc:creator>
<dc:creator>Raanani, Pia</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1737</prism:startingPage>
<prism:endingPage>1739</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414053~db=all~jumptype=rss">
<title>MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?</title>
<dc:title>MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414053~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903350454" />
<dc:creator>Diepstra, Arjan</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1740</prism:startingPage>
<prism:endingPage>1741</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414327~db=all~jumptype=rss">
<title>Another great medical mimic: intravascular lymphoma</title>
<dc:title>Another great medical mimic: intravascular lymphoma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414327~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903350439" />
<dc:creator>Anastasi, John</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1742</prism:startingPage>
<prism:endingPage>1743</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414867~db=all~jumptype=rss">
<title>Early detection of patients with poor risk diffuse large B-cell lymphoma</title>
<dc:title>Early detection of patients with poor risk diffuse large B-cell lymphoma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414867~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903308064" />
<dc:creator>Sehn, Laurie H.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1744</prism:startingPage>
<prism:endingPage>1747</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413916~db=all~jumptype=rss">
<title>Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments</title>
<dc:title>Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413916~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903308049" />
<dc:creator>Hoekstra, Otto S.</dc:creator>
<dc:creator>Boellaard, Ronald</dc:creator>
<dc:creator>Zijlstra, Jos&#xe9;e M.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1748</prism:startingPage>
<prism:endingPage>1749</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414721~db=all~jumptype=rss">
<title>Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes</title>
<dc:title>Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414721~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903308080" />
<dc:creator>Nagai, Hirokazu</dc:creator>
<dc:creator>Terasawa, Teruhiko</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1750</prism:startingPage>
<prism:endingPage>1752</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414777~db=all~jumptype=rss">
<title>Interim 18 F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation - where do we stand?</title>
<dc:title>Interim 18 F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation - where do we stand?</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414777~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903308056" />
<dc:creator>Haioun, Corinne</dc:creator>
<dc:creator>Gallamini, Andrea</dc:creator>
<dc:creator>Itti, Emmanuel</dc:creator>
<dc:creator>Meignan, Michel</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1753</prism:startingPage>
<prism:endingPage>1756</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414340~db=all~jumptype=rss">
<title>Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas - the PETAL trial</title>
<dc:title>Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas - the PETAL trial</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414340~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903308031" />
<dc:creator>M&#xfc;ller, Stefan</dc:creator>
<dc:creator>J&#xf6;ckel, Karl-Heinz</dc:creator>
<dc:creator>H&#xfc;ttmann, Andreas</dc:creator>
<dc:creator>D&#xfc;hrsen, Ulrich</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1757</prism:startingPage>
<prism:endingPage>1760</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413752~db=all~jumptype=rss">
<title>Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation</title>
<dc:title>Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413752~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903308072" />
<dc:creator>Meignan, Michel</dc:creator>
<dc:creator>Sorasio, Roberto</dc:creator>
<dc:creator>Fiore, Francesca</dc:creator>
<dc:creator>Gallamini, Andrea</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1761</prism:startingPage>
<prism:endingPage>1764</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414435~db=all~jumptype=rss">
<title>Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas</title>
<dc:title>Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414435~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903186510" />
<dc:creator>Ng, Andrea K.</dc:creator>
<dc:creator>Martin, Neil E.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1765</prism:startingPage>
<prism:endingPage>1772</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414118~db=all~jumptype=rss">
<title>Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment</title>
<dc:title>Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414118~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903186502" />
<dc:creator>Advani, Ranjana</dc:creator>
<dc:creator>Kohrt, Holbrook</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1773</prism:startingPage>
<prism:endingPage>1784</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413956~db=all~jumptype=rss">
<title>Overcoming resistance in chronic myelogenous leukemia</title>
<dc:title>Overcoming resistance in chronic myelogenous leukemia</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413956~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903267559" />
<dc:creator>Savona, Michael R.</dc:creator>
<dc:creator>Giles, Francis J.</dc:creator>
<dc:creator>Cooper, Susannah</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1785</prism:startingPage>
<prism:endingPage>1793</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414939~db=all~jumptype=rss">
<title>Bone and [ 18 F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults</title>
<dc:title>Bone and [ 18 F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414939~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903189027" />
<dc:creator>Metzger, Monika</dc:creator>
<dc:creator>Hudson, Melissa M.</dc:creator>
<dc:creator>Krasin, Matthew J.</dc:creator>
<dc:creator>Kaste, Sue C.</dc:creator>
<dc:creator>McCarville, Mary B.</dc:creator>
<dc:creator>Shulkin, Barry L.</dc:creator>
<dc:creator>Goodin, Geoffrey S.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1794</prism:startingPage>
<prism:endingPage>1802</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413830~db=all~jumptype=rss">
<title>Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma</title>
<dc:title>Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413830~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903254383" />
<dc:creator>Grapulin, Lavinia</dc:creator>
<dc:creator>Sacco, Mikael</dc:creator>
<dc:creator>Torelli, Fabio</dc:creator>
<dc:creator>Vignetti, Marco</dc:creator>
<dc:creator>Mandelli, Franco</dc:creator>
<dc:creator>Fo&#xe0;, Robin</dc:creator>
<dc:creator>Pulsoni, Alessandro</dc:creator>
<dc:creator>Gentilini, Fabiana</dc:creator>
<dc:creator>Frattarelli, Natalia</dc:creator>
<dc:creator>De Angelis, Federico</dc:creator>
<dc:creator>Annechini, Giorgia</dc:creator>
<dc:creator>Matturro, Angela</dc:creator>
<dc:creator>Cavalieri, Elena</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1803</prism:startingPage>
<prism:endingPage>1808</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414659~db=all~jumptype=rss">
<title>Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence</title>
<dc:title>Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414659~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903200790" />
<dc:creator>Artz, Andrew S.</dc:creator>
<dc:creator>Wickrema, Amittha</dc:creator>
<dc:creator>Stock, Wendy</dc:creator>
<dc:creator>Odenike, Toyosi</dc:creator>
<dc:creator>Larson, Richard A.</dc:creator>
<dc:creator>Godley, Lucy A.</dc:creator>
<dc:creator>Joseph, Loren</dc:creator>
<dc:creator>Lin, Shang</dc:creator>
<dc:creator>Dew, Alexander</dc:creator>
<dc:creator>van Besien, Koen</dc:creator>
<dc:creator>Rich, Elizabeth</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1809</prism:startingPage>
<prism:endingPage>1817</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414904~db=all~jumptype=rss">
<title>Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma</title>
<dc:title>Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414904~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903258780" />
<dc:creator>Tamura, Kazuo</dc:creator>
<dc:creator>Takamatsu, Yasushi</dc:creator>
<dc:creator>Shibata, Takao</dc:creator>
<dc:creator>Ishitsuka, Kenji</dc:creator>
<dc:creator>Sasaki, Hidenori</dc:creator>
<dc:creator>Suzumiya, Junji</dc:creator>
<dc:creator>Katsuya, Hiroo</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1818</prism:startingPage>
<prism:endingPage>1823</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414583~db=all~jumptype=rss">
<title>Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma</title>
<dc:title>Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414583~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903216796" />
<dc:creator>Gandolfi, Letizia</dc:creator>
<dc:creator>Pileri, Stefano A.</dc:creator>
<dc:creator>Martelli, Maurizio</dc:creator>
<dc:creator>Petti, Maria Concetta</dc:creator>
<dc:creator>Perrotti, Alessio</dc:creator>
<dc:creator>De Renzo, Amalia</dc:creator>
<dc:creator>Zaja, Francesco</dc:creator>
<dc:creator>Baccarani, Michele</dc:creator>
<dc:creator>Zinzani, Pier Luigi</dc:creator>
<dc:creator>Venturini, Filippo</dc:creator>
<dc:creator>Broccoli, Alessandro</dc:creator>
<dc:creator>Fina, Maria Paola</dc:creator>
<dc:creator>Pellegrini, Cinzia</dc:creator>
<dc:creator>Stefoni, Vittorio</dc:creator>
<dc:creator>Derenzini, Enrico</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1824</prism:startingPage>
<prism:endingPage>1829</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414406~db=all~jumptype=rss">
<title>Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma</title>
<dc:title>Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414406~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903242628" />
<dc:creator>Spector, Nelson</dc:creator>
<dc:creator>Natkunam, Yasodha</dc:creator>
<dc:creator>Scheliga, Adriana</dc:creator>
<dc:creator>Britto, Luciana</dc:creator>
<dc:creator>Morais, Jos&#xe9; Carlos</dc:creator>
<dc:creator>Biasoli, Irene</dc:creator>
<dc:creator>Lossos, Izidore S.</dc:creator>
<dc:creator>Azambuja, Denize</dc:creator>
<dc:creator>Pulcheri, Wolmar</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1830</prism:startingPage>
<prism:endingPage>1836</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414836~db=all~jumptype=rss">
<title>BCL2 -938C&#x3e;A polymorphism and disease progression in chronic lymphocytic leukemia</title>
<dc:title>BCL2 -938C&#x3e;A polymorphism and disease progression in chronic lymphocytic leukemia</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414836~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903207530" />
<dc:creator>N&#xfc;ckel, Holger</dc:creator>
<dc:creator>Stilgenbauer, Stephan</dc:creator>
<dc:creator>Siffert, Winfried</dc:creator>
<dc:creator>D&#xf6;hner, Hartmut</dc:creator>
<dc:creator>D&#xfc;rig, Jan</dc:creator>
<dc:creator>D&#xfc;hrsen, Ulrich</dc:creator>
<dc:creator>Benner, Axel</dc:creator>
<dc:creator>Zenz, Thorsten</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1837</prism:startingPage>
<prism:endingPage>1842</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414741~db=all~jumptype=rss">
<title>Random serum methotrexate determinations for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia</title>
<dc:title>Random serum methotrexate determinations for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414741~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903216812" />
<dc:creator>Chapa-Rodr&#xed;guez, Adri&#xe1;n</dc:creator>
<dc:creator>Sandoval-Gonz&#xe1;lez, Adriana</dc:creator>
<dc:creator>G&#xf3;mez-Almaguer, David</dc:creator>
<dc:creator>Jaime-P&#xe9;rez, Jos&#xe9; Carlos</dc:creator>
<dc:creator>Gonz&#xe0;lez-Llano, Oscar</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1843</prism:startingPage>
<prism:endingPage>1847</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414495~db=all~jumptype=rss">
<title>Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin</title>
<dc:title>Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414495~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903216788" />
<dc:creator>Raptis, Anastasios</dc:creator>
<dc:creator>Agha, Mounzer</dc:creator>
<dc:creator>Natale, James</dc:creator>
<dc:creator>Luong, The Minh</dc:creator>
<dc:creator>Schlesselman, James J.</dc:creator>
<dc:creator>Boyiadzis, Michael</dc:creator>
<dc:creator>Redner, Robert L.</dc:creator>
<dc:creator>Sehgal, Rajesh</dc:creator>
<dc:creator>McHayleh, Wassim</dc:creator>
<dc:creator>Foon, Kennteh A.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1848</prism:startingPage>
<prism:endingPage>1853</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414069~db=all~jumptype=rss">
<title>Hematopoiesis-related microRNA expression in myelodysplastic syndromes</title>
<dc:title>Hematopoiesis-related microRNA expression in myelodysplastic syndromes</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414069~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903147645" />
<dc:creator>Gaya, Anna</dc:creator>
<dc:creator>Gel, Bernat</dc:creator>
<dc:creator>Diaz, Tania</dc:creator>
<dc:creator>Valera, Sandra</dc:creator>
<dc:creator>Rozman, Mar&#xed;a</dc:creator>
<dc:creator>Montserrat, Emili</dc:creator>
<dc:creator>Monzo, Mariano</dc:creator>
<dc:creator>Navarro, Alfons</dc:creator>
<dc:creator>Nomdedeu, Benet</dc:creator>
<dc:creator>Belkaid, Mohamed</dc:creator>
<dc:creator>Pons, Aina</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1854</prism:startingPage>
<prism:endingPage>1859</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413792~db=all~jumptype=rss">
<title>Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma</title>
<dc:title>Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413792~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903216804" />
<dc:creator>Kabani, Karieshma</dc:creator>
<dc:creator>Yang, Shihong</dc:creator>
<dc:creator>Sze, Daniel M.</dc:creator>
<dc:creator>Aklilu, Esther</dc:creator>
<dc:creator>Gibson, John</dc:creator>
<dc:creator>Joshua, Douglas E.</dc:creator>
<dc:creator>Kennedy, Nola</dc:creator>
<dc:creator>Ho, Phoebe Joy</dc:creator>
<dc:creator>Spencer, Andrew</dc:creator>
<dc:creator>Brown, Ross D.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1860</prism:startingPage>
<prism:endingPage>1864</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414228~db=all~jumptype=rss">
<title>Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma</title>
<dc:title>Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414228~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903221010" />
<dc:creator>Wickrema, Amittha</dc:creator>
<dc:creator>Platanias, Leonidas C.</dc:creator>
<dc:creator>Zimmerman, Todd</dc:creator>
<dc:creator>Unno, Kenji</dc:creator>
<dc:creator>Zhou, Ying</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1865</prism:startingPage>
<prism:endingPage>1871</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414559~db=all~jumptype=rss">
<title>Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?</title>
<dc:title>Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414559~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903150821" />
<dc:creator>For the Swedish Adult All Group</dc:creator>
<dc:creator>Smedmyr, Bengt</dc:creator>
<dc:creator>H&#xe4;gglund, Hans</dc:creator>
<dc:creator>Bj&#xf6;rkholm, Magnus</dc:creator>
<dc:creator>Hallb&#xf6;&#xf6;k, Helene</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1872</prism:startingPage>
<prism:endingPage>1874</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413727~db=all~jumptype=rss">
<title>Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV</title>
<dc:title>Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413727~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903297531" />
<dc:creator>Rimsza, Lisa M.</dc:creator>
<dc:creator>Rosenwald, Andreas</dc:creator>
<dc:creator>Jaffe, Elaine S.</dc:creator>
<dc:creator>Staudt, Louis M.</dc:creator>
<dc:creator>Gascoyne, Randy D.</dc:creator>
<dc:creator>Delabie, Jan</dc:creator>
<dc:creator>Chan, Wing C.</dc:creator>
<dc:creator>Campo, Elias</dc:creator>
<dc:creator>Braziel, Rita M.</dc:creator>
<dc:creator>Murphy, Shawn P.</dc:creator>
<dc:creator>Fernandez, Diane R.</dc:creator>
<dc:creator>Wilkinson, Sarah T.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1875</prism:startingPage>
<prism:endingPage>1878</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414283~db=all~jumptype=rss">
<title>Primary myelofibrosis relapsed with duodenal myeloid sarcoma after allogeneic stem cell transplantation</title>
<dc:title>Primary myelofibrosis relapsed with duodenal myeloid sarcoma after allogeneic stem cell transplantation</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414283~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903207555" />
<dc:creator>Huang, Qin</dc:creator>
<dc:creator>Lu, Ying</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1879</prism:startingPage>
<prism:endingPage>1881</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413868~db=all~jumptype=rss">
<title>Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec</title>
<dc:title>Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413868~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903242610" />
<dc:creator>Ganjoo, Kristen N.</dc:creator>
<dc:creator>Demetri, George D.</dc:creator>
<dc:creator>Jacobs, Charlotte</dc:creator>
<dc:creator>Patel, Shreyaskumar</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1882</prism:startingPage>
<prism:endingPage>1884</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413930~db=all~jumptype=rss">
<title>Human immunodeficiency virus and chronic lymphocytic leukemia</title>
<dc:title>Human immunodeficiency virus and chronic lymphocytic leukemia</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413930~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903216820" />
<dc:creator>Aboulafia, David</dc:creator>
<dc:creator>Pantanowitz, Liron</dc:creator>
<dc:creator>Cole, Joanna</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1885</prism:startingPage>
<prism:endingPage>1888</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413710~db=all~jumptype=rss">
<title>The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy</title>
<dc:title>The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413710~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903216838" />
<dc:creator>Zhu, Jian-Bin</dc:creator>
<dc:creator>Din, Ban-He</dc:creator>
<dc:creator>Liu, Ding-Shen</dc:creator>
<dc:creator>Liu, Xiaolin</dc:creator>
<dc:creator>Li, Yu-Feng</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1889</prism:startingPage>
<prism:endingPage>1891</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413890~db=all~jumptype=rss">
<title>Clonal evolution to histiocytic sarcoma with the BCR / ABL rearrangement 14 years after acute lymphoblastic leukemia</title>
<dc:title>Clonal evolution to histiocytic sarcoma with the BCR / ABL rearrangement 14 years after acute lymphoblastic leukemia</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413890~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903216846" />
<dc:creator>Larsson, Gun</dc:creator>
<dc:creator>M&#xe5;nsson, Ingrid</dc:creator>
<dc:creator>Gy&#xf6;rgy, Czabafy</dc:creator>
<dc:creator>Warenholt, Janina</dc:creator>
<dc:creator>Dictor, Michael</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1892</prism:startingPage>
<prism:endingPage>1895</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414264~db=all~jumptype=rss">
<title>Knockdown of LYL1 impaired proliferation of CD34(+) myeloid leukemia cells</title>
<dc:title>Knockdown of LYL1 impaired proliferation of CD34(+) myeloid leukemia cells</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414264~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903225367" />
<dc:creator>Liu, Wei</dc:creator>
<dc:creator>Hu, Xiao-Jing</dc:creator>
<dc:creator>Meng, Yue-Sheng</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1896</prism:startingPage>
<prism:endingPage>1899</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916414634~db=all~jumptype=rss">
<title>Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative</title>
<dc:title>Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916414634~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903234005" />
<dc:creator>Hohaus, Stefan</dc:creator>
<dc:creator>Leone, Giuseppe</dc:creator>
<dc:creator>Teofili, Luciana</dc:creator>
<dc:creator>Larocca, Luigi M.</dc:creator>
<dc:creator>Arena, Vincenzo</dc:creator>
<dc:creator>Vannata, Barbara</dc:creator>
<dc:creator>Mansueto, Giovanna</dc:creator>
<dc:creator>Massini, Giuseppina</dc:creator>
<dc:creator>D'Al&#xf2;, Francesco</dc:creator>
<dc:creator>Tisi, Maria Chiara</dc:creator>
<dc:creator>Bozzoli, Valentina</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1900</prism:startingPage>
<prism:endingPage>1903</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916413909~db=all~jumptype=rss">
<title>Corrigenda</title>
<dc:title>Corrigenda</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916413909~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903396049" />
<prism:volume>50</prism:volume>
<prism:number>11</prism:number>
<prism:startingPage>1904</prism:startingPage>
<prism:endingPage>1904</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916415087~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916245123~db=all~jumptype=rss">
<title>Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival</title>
<dc:title>Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916245123~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903159384" />
<dc:creator>Zenz, Thorsten</dc:creator>
<dc:creator>Stilgenbauer, Stephan</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1559</prism:startingPage>
<prism:endingPage>1561</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916244454~db=all~jumptype=rss">
<title>The role of Toll-like receptors in chronic B cell malignancies</title>
<dc:title>The role of Toll-like receptors in chronic B cell malignancies</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916244454~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903115410" />
<dc:creator>Caligaris-Cappio, Federico</dc:creator>
<dc:creator>Frenquelli, Michela</dc:creator>
<dc:creator>Simonetti, Giorgia</dc:creator>
<dc:creator>Bertilaccio, Maria T. S.</dc:creator>
<dc:creator>Muzio, Marta</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1573</prism:startingPage>
<prism:endingPage>1580</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916245147~db=all~jumptype=rss">
<title>A new co-operative group: the European Myeloma Network Trialist Group</title>
<dc:title>A new co-operative group: the European Myeloma Network Trialist Group</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916245147~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903191874" />
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1581</prism:startingPage>
<prism:endingPage>1588</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916245062~db=all~jumptype=rss">
<title>Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901</title>
<dc:title>Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916245062~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903150839" />
<dc:creator>Nattam, Sreenivasa</dc:creator>
<dc:creator>Gockerman, Jon</dc:creator>
<dc:creator>Perry, Michael C.</dc:creator>
<dc:creator>Hohl, Raymond</dc:creator>
<dc:creator>Hurd, David</dc:creator>
<dc:creator>Rai, Kanti R.</dc:creator>
<dc:creator>Peterson, Bercedis L.</dc:creator>
<dc:creator>Byrd, John C.</dc:creator>
<dc:creator>Larson, Richard A.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1589</prism:startingPage>
<prism:endingPage>1596</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916244379~db=all~jumptype=rss">
<title>p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy</title>
<dc:title>p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916244379~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903165241" />
<dc:creator>O'Brien, Susan</dc:creator>
<dc:creator>Lin, Katherine I.</dc:creator>
<dc:creator>Abruzzo, Lynne</dc:creator>
<dc:creator>Wierda, William</dc:creator>
<dc:creator>Admirand, Joan</dc:creator>
<dc:creator>Schlette, Ellen J.</dc:creator>
<dc:creator>Tam, Constantine</dc:creator>
<dc:creator>Keating, Michael J.</dc:creator>
<dc:creator>Lerner, Susan</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1597</prism:startingPage>
<prism:endingPage>1605</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916244071~db=all~jumptype=rss">
<title>Clinical outcome in patients with small intestinal non-Hodgkin lymphoma</title>
<dc:title>Clinical outcome in patients with small intestinal non-Hodgkin lymphoma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916244071~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903147629" />
<dc:creator>Tanaka, Yukie</dc:creator>
<dc:creator>Tanihara, Aki</dc:creator>
<dc:creator>Kawamura, Yutaka</dc:creator>
<dc:creator>Kiyosaki, Hirokazu</dc:creator>
<dc:creator>Higuchi, Takakazu</dc:creator>
<dc:creator>Nishida, Junji</dc:creator>
<dc:creator>Konishi, Fumio</dc:creator>
<dc:creator>Kanda, Yoshinobu</dc:creator>
<dc:creator>Nakasone, Hideki</dc:creator>
<dc:creator>Okuda, Shinya</dc:creator>
<dc:creator>Yamazaki, Rie</dc:creator>
<dc:creator>Kako, Shinichi</dc:creator>
<dc:creator>Oshima, Kumi</dc:creator>
<dc:creator>Sato, Miki</dc:creator>
<dc:creator>Terasako, Kiriko</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1618</prism:startingPage>
<prism:endingPage>1624</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916244248~db=all~jumptype=rss">
<title>Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with &#x3e;20 years follow-up</title>
<dc:title>Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with &#x3e;20 years follow-up</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916244248~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903161075" />
<dc:creator>Bennett, John M.</dc:creator>
<dc:creator>Glick, John H.</dc:creator>
<dc:creator>Hong, Fangxin</dc:creator>
<dc:creator>Wiernik, Peter H.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1632</prism:startingPage>
<prism:endingPage>1641</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916245194~db=all~jumptype=rss">
<title>Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas</title>
<dc:title>Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916245194~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903156729" />
<dc:creator>Nielsen, Johan L.</dc:creator>
<dc:creator>Karkkainen, Marika J.</dc:creator>
<dc:creator>Tainola, Tapio</dc:creator>
<dc:creator>S&#xf8;rensen, Annette B.</dc:creator>
<dc:creator>Pedersen, Finn S.</dc:creator>
<dc:creator>D'Amore, Francesco</dc:creator>
<dc:creator>Bendix, Knud</dc:creator>
<dc:creator>S&#xf8;rensen, Flemming B.</dc:creator>
<dc:creator>J&#xf8;rgensen, Judit M.</dc:creator>
<dc:creator>Funder, Anette</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1647</prism:startingPage>
<prism:endingPage>1660</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916244573~db=all~jumptype=rss">
<title>Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL + cell to Imatinib and Nilotinib</title>
<dc:title>Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL + cell to Imatinib and Nilotinib</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916244573~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903150847" />
<dc:creator>Dillmann, Falk</dc:creator>
<dc:creator>Laufs, Stephanie</dc:creator>
<dc:creator>Sperandio, Markus</dc:creator>
<dc:creator>Calandra, Gary</dc:creator>
<dc:creator>Wenz, Frederik</dc:creator>
<dc:creator>Zeller, W. Jens</dc:creator>
<dc:creator>Fruehauf, Stefan</dc:creator>
<dc:creator>Veldwijk, Marlon R.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1676</prism:startingPage>
<prism:endingPage>1686</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916245163~db=all~jumptype=rss">
<title>The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide&#xb1;rituximab: results of a randomized phase II trial</title>
<dc:title>The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide&#xb1;rituximab: results of a randomized phase II trial</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916245163~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903186494" />
<dc:creator>Rule, Simon A. J.</dc:creator>
<dc:creator>Qian, Wendi</dc:creator>
<dc:creator>Smith, Paul</dc:creator>
<dc:creator>Gambell, Jo</dc:creator>
<dc:creator>Eve, Heather E.</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1709</prism:startingPage>
<prism:endingPage>1711</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916245182~db=all~jumptype=rss">
<title>Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma</title>
<dc:title>Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916245182~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903161059" />
<dc:creator>McMullin, Mary F.</dc:creator>
<dc:creator>Cuthbert, Robert J. G.</dc:creator>
<dc:creator>Richardson, Deborah</dc:creator>
<dc:creator>Furby, Darshayani</dc:creator>
<dc:creator>McNicholl, Feargal</dc:creator>
<dc:creator>Ramanujam, Deivasikamani</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1721</prism:startingPage>
<prism:endingPage>1722</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916244552~db=all~jumptype=rss">
<title>Thymidylate syntase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma?</title>
<dc:title>Thymidylate syntase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma?</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916244552~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903147611" />
<dc:creator>Berglund, Mattias</dc:creator>
<dc:creator>Roos, G&#xf6;ran</dc:creator>
<dc:creator>Thunberg, Ulf</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1723</prism:startingPage>
<prism:endingPage>1725</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
<item rdf:about="http://www.informaworld.com/smpp/content~content=a916244352~db=all~jumptype=rss">
<title>Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone&#xa0;-&#xa0;rituximab refractory patients</title>
<dc:title>Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone&#xa0;-&#xa0;rituximab refractory patients</dc:title>
<link>http://www.informaworld.com/smpp/content~content=a916244352~db=all~jumptype=rss</link>
<description>
</description>
<dc:identifier rdf:resource="doi:10.3109/10428190903144667" />
<dc:creator>Sieniawski, Michal</dc:creator>
<dc:creator>Bhartia, Shilpa</dc:creator>
<dc:creator>Wilkinson, Jennifer</dc:creator>
<dc:creator>Proctor, Stephen John</dc:creator>
<prism:volume>50</prism:volume>
<prism:number>10</prism:number>
<prism:startingPage>1726</prism:startingPage>
<prism:endingPage>1730</prism:endingPage>
<prism:isPartOf rdf:resource="http://www.informaworld.com/smpp/title~group=g916245403~db=all" />
</item>
</rdf:RDF>

















    





  
  
  


  
  
  


  
  
  







  
  
    
  





  
  
  


  
  
  


  
    
  
  


  

  

  
    
      
  
  
    
  


    
  

  
  
  
    
  


  
  
  


  
  
  
    
  



  
  
  


  
  
  


  
  
  


  
  
  
    
  



  
    
  
  


  

  

  

  



  
  
  













    
 

  

  
  
  
    
  


  
  
  
    
  



  
  
  
  



  
    
  
  


    

    
      
        
        
  
  
    
  


        
      
    
    
    
  
  


    

    
      
  
  


    

    
  
  


    
    
    

      

        
          
          

          

          
            
              
  
  


            
            
  
  
    
  



            
            
            
          
    
          
  
  


          
  
  


          
  
  



        
      
    
    

    
    
    	
    	 
      
      
    
    
    
      
  
  


    

    

    
    
    

    

    
  






  
  



  
  



  
  




  
  







  


  
  
  
  



  





  
  







  

  

  

  
    
  
  


  

  
  
  
  
    
    
  

  

  

  

  
  

  

  
    
  
  
    
  
  
    
  

  
    
  
  
    
  

  
    
  
  
    
  
  
    
      
    
  
  
    
  
  
    
      
    
  
  
    
  

  

    
    
  
    
    
  

    

    
      
    
  
      
    
   
      
    
  
    

    
    
      
    
  
    
    
      
    
  
    
    
  
    
    
  

  

  
  
  
    
  
  
    
  

  

  

  
    
  

  

  

  
    
  

  

  

  
    
  
  
  
    
  

  
    
      
    
  

  
    
  
  
    
  
  
    
  

  
    
  

  







